General Information of Drug Transporter (DT)
DT ID DTD0110 Transporter Info
Gene Name SLC16A6
Transporter Name Monocarboxylate transporter 7
Gene ID
9120
UniProt ID
O15403
Post-Translational Modification of This DT
Overview of SLC16A6 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Phosphorylation X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC16A6 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

220

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC16A6 Lysine 220 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        10 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC16A6 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

234

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Serine 234 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC16A6 [2] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

237

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Serine 237 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC16A6 [2] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

240

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Serine 240 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC16A6 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

247

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Serine 247 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC16A6 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

273

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Serine 273 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC16A6 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

277

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Serine 277 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC16A6 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

287

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Serine 287 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC16A6 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

312

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Serine 312 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC16A6 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

451

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Serine 451 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC16A6 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

456

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Serine 456 has the potential to affect its expression or activity.

  Threonine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC16A6 [3] , [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

231

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Threonine 231 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC16A6 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

233

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Threonine 233 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC16A6 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

245

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Threonine 245 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC16A6 [9] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

246

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Threonine 246 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC16A6 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

253

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Threonine 253 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC16A6 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

255

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Threonine 255 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC16A6 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

272

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Threonine 272 has the potential to affect its expression or activity.

  Tyrosine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC16A6 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

224

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Tyrosine 224 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC16A6 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

314

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Tyrosine 314 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC16A6 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

450

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Tyrosine 450 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC16A6 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

455

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC16A6 Tyrosine 455 has the potential to affect its expression or activity.
References
1 Monoclonal antibody cocktail as an enrichment tool for acetylome analysis. Anal Chem. 2011 May 15;83(10):3623-6.
2 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
3 Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
4 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
5 Identification of Candidate Casein Kinase 2 Substrates in Mitosis by Quantitative Phosphoproteomics. Front Cell Dev Biol. 2017 Nov 22;5:97.
6 Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.
7 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
8 An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
9 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
10 Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell lines. J Proteomics. 2015 Sep 8;127(Pt B):247-58.
11 Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
12 Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.